LONG-TERM PASI AND PRO IMPROVEMENT FOR PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS OVER 5 YEARS OF IXEKIZUMAB TREATMENT: UNCOVER-1 AND-2 STUDIES

Gooderham, M; Hawkes, JE; Paul, C; Burge, R; Gallo, G; See, K; Mckean-Matthews, M; Malatestinic, W; Foley, P; Porsdal, V

ACTA DERMATO-VENEREOLOGICA, 2022; 102 (): 46